Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | XBP1 | P17861 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | NQO1 | P15559 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4628241 | 0.90 | SLC6A2 (0.50) | AAK1CYP3A4LMNACYP2C19PTGS1 | |
| SCHEMBL123415 | 0.78 | MAPT (0.55) | LMNAMAPTHPGDPOLBXBP1 | |
| SCHEMBL20851318 | 0.71 | MAPT (0.58) | AAK1CYP3A4LMNAMAPTHPGD | |
| SCHEMBL29690404 | 0.71 | USP2 (0.47) | CYP3A4LMNAMAPTCYP2C9KDM4E | |
| SCHEMBL4527180 | 0.71 | MAPT (0.50) | LMNAMAPTHPGDPOLBXBP1 | |
| SCHEMBL9057992 | 0.71 | AAK1 (0.53) | AAK1CYP3A4LMNAMAPTHPGD | |
| SCHEMBL7329813 | 0.70 | NQO1 (0.67) | LMNAMAPTHPGDPOLBXBP1 | |
| SCHEMBL2231003 | 0.70 | TSHR (0.50) | CYP3A4LMNAMAPTHPGDPOLB | |
| SCHEMBL3182331 | 0.70 | HPGD (0.66) | LMNAMAPTHPGDPOLBXBP1 | |
| SCHEMBL13263721 | 0.70 | USP2 (0.58) | CYP3A4LMNAMAPTPOLBCYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050037048-A1 | Medical devices containing antioxidant and therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2005-02-17 | — | — | US | claimed |
| EP-2708247-B1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENT NEUROMODULATION CORP (US) | 2017-06-14 | — | — | EP | disclosed |
| US-9220811-B2 | Implantable or insertable medical devices | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| EP-2711031-A2 | Implantable or Insertable Medical Devices | Boston Scientific Neuromodulation Corporation (US) | 2014-03-26 | — | — | EP | disclosed |
| EP-2708247-A1 | Implantable or Insertable Medical Devices | Boston Scientific Neuromodulation Corporation (US) | 2014-03-19 | — | — | EP | disclosed |
| EP-2344207-B1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENT NEUROMODULATION (US) | 2013-12-25 | — | — | EP | disclosed |
| US-20100256720-A1 | IMPLANTABLE OR INSERTABLE MEDICAL DEVICES | BOSTON SCIENTIFIC NEUROMODULATION CORPORATION (US) | 2010-10-07 | — | — | US | disclosed |
| US-20090246292-A1 | ANTIMICROBIAL FORMULATIONS COMPRISING A QUINONE AND A COPPER SALT | SYNTOPIX LIMITED (GB) | 2009-10-01 | — | — | US | disclosed |
| US-20060182792-A1 | Liposome-forming compositions | BERNINA BIOSYSTEMS GMBH (DE) | 2006-08-17 | — | — | US | disclosed |
| US-20050064011-A1 | Implantable or insertable medical devices containing phenolic compound for inhibition of restenosis | BOSTON SCIENTIFIC SCIMED, INC. | 2005-03-24 | — | — | US | disclosed |
| US-20050037048-A1 | Medical devices containing antioxidant and therapeutic agent | BOSTON SCIENTIFIC SCIMED, INC. | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060182792-A1 | Liposome-forming compositions | CLPTM1L, LIPA, LYPLAL1 | AAK1 3118/4885CYP3A4 4417/4885LMNA 614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.